[go: up one dir, main page]

Revision history of "Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group" (Q27824835)

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

(latest | earliest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

10 December 2024

30 September 2023

6 July 2022

15 February 2022

12 January 2022

30 September 2021

13 September 2021

21 June 2021

  • curprev 11:4111:41, 21 June 2021 KrBot talk contribs 27,019 bytes −1 Set a claim value: title (P1476): Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group undo (restore)
  • curprev 11:4111:41, 21 June 2021 KrBot talk contribs 27,020 bytes −1 Changed Dutch label: Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group undo (restore)
  • curprev 11:4111:41, 21 June 2021 KrBot talk contribs 27,021 bytes −1 Changed English label: Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group undo (restore)
  • curprev 11:4111:41, 21 June 2021 KrBot talk contribs 27,022 bytes −1 Changed Asturian label: Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group undo (restore)

11 September 2020

17 August 2019

24 July 2019

  • curprev 09:2409:24, 24 July 2019 ԱշբոտՏՆՂ talk contribs 26,283 bytes +214 Updated Item: hy:description:2005 թվականի հուլիսին հրատարակված գիտական հոդված, hyw:description:2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած undo (restore)

14 April 2019

23 March 2019

13 March 2019

22 December 2018

8 November 2017

10 September 2017

  • curprev 17:4417:44, 10 September 2017 Emijrpbot talk contribs 24,520 bytes +3,970 Updated Item: BOT - Adding descriptions (48 languages): ast, bg, bn, ca, de, el, eo, es, et, fi, fr, gl, he, hu, ja, ka, ko, lt, nan, nb, nn, oc, pl, pt-br, ro, ru, sq, sr-ec, sr-el, sv, tg, tg-cyrl, th, tl, tr, uk, vi, wuu, yue, zh... undo (restore)

1 July 2017

29 May 2017

20 February 2017

30 January 2017

15 December 2016

13 December 2016

26 November 2016

21 November 2016

16 November 2016

13 November 2016

(latest | earliest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)